• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Why Sonic Healthcare (ASX:SHL) Is Up 5.7% After Stronger FY26 Revenue And Earnings Results

    Simply Wall St·08/20/2026 07:30:28
    Listen to the news
    • Sonic Healthcare Limited has now reported its full-year results for the period ended 30 June 2026, with revenue of A$10,974.12 million, sales of A$10,867.37 million and net income of A$608.29 million, all higher than the prior year.
    • The company also delivered higher basic earnings per share from continuing operations of A$1.231, indicating improved profitability on a per-share basis compared with the previous year.
    • We’ll now examine how Sonic Healthcare’s stronger full-year revenue and earnings performance could influence the existing investment narrative for the company.

    The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

    Sonic Healthcare Investment Narrative Recap

    To own Sonic Healthcare, you need to believe in long term growth in global diagnostic testing and the company’s ability to convert that demand into resilient earnings. The latest full year results, with higher revenue, net income and EPS, support this case in the near term. However, they do not remove key risks such as integration challenges from acquisitions and ongoing pressure from regulatory and reimbursement changes, which remain important short term swing factors.

    The most relevant update is the full year 2026 earnings announcement itself, showing revenue of A$10,974.12 million and net income of A$608.29 million, both above the prior year. This reinforces the existing catalyst that scale benefits from past acquisitions and investments can support earnings growth, while still leaving questions about how sustainable margins will be amid higher labor costs and reimbursement headwinds across Sonic’s core markets.

    Yet behind these stronger numbers, investors should still be aware of the risk that regulatory and reimbursement changes could...

    Read the full narrative on Sonic Healthcare (it's free!)

    Sonic Healthcare's narrative projects A$11.9 billion revenue and A$749.2 million earnings by 2029. This requires 4.6% yearly revenue growth and about a A$209.8 million earnings increase from A$539.4 million today.

    Uncover how Sonic Healthcare's forecasts yield a A$23.36 fair value, in line with its current price.

    Exploring Other Perspectives

    ASX:SHL 1-Year Stock Price Chart
    ASX:SHL 1-Year Stock Price Chart

    Some of the lowest ranked analysts were assuming only about A$12.2 billion of revenue and A$778.7 million of earnings by 2029, which is a much more cautious view than the consensus. When you compare that with today’s stronger full year numbers and the ongoing integration of LADR and Sonic Swiss, you can see how opinions on Sonic’s potential range widely and why it is worth exploring several different viewpoints before you decide what you believe.

    Explore 10 other fair value estimates on Sonic Healthcare - why the stock might be worth over 3x more than the current price!

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Ready For A Different Approach?

    The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.